Acute Investment Advisory’s ProShares Ultra MidCap400 MVV Stock Holding History
Bought
Maintained
Sold
Other funds holding MVV
LC
IFWM
KWM
CCM
TRCT
SBL
HIS
Acute Investment Advisory's MVV Position: Q1 2022 in Review
Acute Investment Advisory sold out of ProShares Ultra MidCap400 (MVV) in Q1 2022, closing a stake of 17,508 shares — an estimated $1.24M sold.
Acute Investment Advisory first reported a position in MVV in Q4 2021 and held it in 1 quarter. The position peaked at $1.24M in Q4 2021. 28 funds tracked by Wall St. Rank hold MVV as of Q1 2022.
- Acute Investment Advisory reported no remaining ProShares Ultra MidCap400 position as of Q1 2022 after selling out during the quarter.
- Acute Investment Advisory sold 17,508 ProShares Ultra MidCap400 shares in Q1 2022, an estimated $1.24M.
- Acute Investment Advisory first reported a position in ProShares Ultra MidCap400 in Q4 2021 and held it in 1 quarter.
- Acute Investment Advisory's ProShares Ultra MidCap400 position peaked at $1.24M in Q4 2021.
- 28 funds tracked by Wall St. Rank held ProShares Ultra MidCap400 as of Q1 2022.
Based on Acute Investment Advisory's 13F filing for Q1 2022, filed 31 Aug 2022.